Rescheduling Notification of the Public Teleconference of the President's Commission on Combating Drug Addiction and the Opioid Crisis (Commission), 32587 [2017-14835]

Download as PDF Federal Register / Vol. 82, No. 134 / Friday, July 14, 2017 / Notices FOR FURTHER INFORMATION CONTACT: Gerard Poliquin, Secretary of the Board, Telephone: 703–518–6304. Gerard Poliquin, Secretary of the Board. [FR Doc. 2017–14924 Filed 7–12–17; 4:15 pm] BILLING CODE 7535–01–P EXECUTIVE OFFICE OF THE PRESIDENT Office of National Drug Control Policy Rescheduling Notification of the Public Teleconference of the President’s Commission on Combating Drug Addiction and the Opioid Crisis (Commission) Office of National Drug Control Policy (ONDCP). ACTION: Notice of rescheduling of teleconference. AGENCY: ONDCP is issuing this notice to advise the public that the Commission is rescheduling the teleconference of the President’s Commission on Combating Drug Addiction and the Opioid Crisis that was previously scheduled for Monday, July 17th at 4 p.m. EST. The purpose of the meeting is to review a draft interim report that will be posted on ONDCP’s Commission Web site listed below before the teleconference. DATES: The teleconference will be held on Monday, July 31st at 4 p.m. EST. ADDRESSES: There will be no physical address. The public may call (800) 260– 0718 (Access Code 426289) to listen. Please call five minutes before the start time. If you are part of an organization, please try to consolidate use to as few lines as possible. FOR FURTHER INFORMATION CONTACT: General information concerning the Commission and its meetings can be found on ONDCP’s Web site at https:// www.whitehouse.gov/ondcp/presidentscommission. Any member of the public who wants to obtain information about the Commission or its meetings that is not already on ONDCP’s Web site or who wants to submit written comments for the Commission’s consideration may contact Michael Passante, Designated Federal Officer (DFO) via email at commission@ondcp.eop.gov or telephone at (202) 395–6709. Please note that ONDCP may post such written comments publicly on our Web site, including names and contact information that are submitted. SUPPLEMENTARY INFORMATION: The Commission was established in accordance with E.O. 13784 of March mstockstill on DSK30JT082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:44 Jul 13, 2017 Jkt 241001 29, 2017, the Commission’s charter, and the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App. 2, to obtain advice and recommendations for the President regarding drug issues. The Executive Order, charter, and information on the Members of the Commission are available on ONDCP’s Web site. The Commission will function solely as an advisory body and will make recommendations regarding policies and practices for combating drug addiction with particular focus on the current opioid crisis in the United States. The Commission’s final report is due October 1, 2017 unless there is an extension. Per E.O. 13784, the Commission shall: a. Identify and describe the existing Federal funding used to combat drug addiction and the opioid crisis; b. Assess the availability and accessibility of drug addiction treatment services and overdose reversal throughout the country and identify areas that are underserved; c. Identify and report on best practices for addiction prevention, including healthcare provider education and evaluation of prescription practices, collaboration between State and Federal officials, and the use and effectiveness of State prescription drug monitoring programs; d. Review the literature evaluating the effectiveness of educational messages for youth and adults with respect to prescription and illicit opioids; e. Identify and evaluate existing Federal programs to prevent and treat drug addiction for their scope and effectiveness, and make recommendations for improving these programs; and; f. Make recommendations to the President for improving the Federal response to drug addiction and the opioid crisis. Dated: July 11, 2017. Michael Passante, Acting General Counsel, Designated Federal Officer. [FR Doc. 2017–14835 Filed 7–13–17; 8:45 am] BILLING CODE 3280–F5–P NUCLEAR REGULATORY COMMISSION [NRC–2017–0001] Sunshine Act Meeting Notice Weeks of July 17, 24, 31, August 7, 14, 21, 2017. PLACE: Commissioners’ Conference Room, 11555 Rockville Pike, Rockville, Maryland. DATE: PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 STATUS: 32587 Public and Closed. Week of July 17, 2017 There are no meetings scheduled for the week of July 17, 2017. Week of July 24, 2017—Tentative There are no meetings scheduled for the week of July 24, 2017. Week of July 31, 2017—Tentative There are no meetings scheduled for the week of July 31, 2017. Week of August 7, 2017—Tentative There are no meetings scheduled for the week of August 7, 2017. Week of August 14, 2017—Tentative There are no meetings scheduled for the week of August 14, 2017. Week of August 21, 2017—Tentative There are no meetings scheduled for the week of August 21, 2017. * * * * * The schedule for Commission meetings is subject to change on short notice. For more information or to verify the status of meetings, contact Denise McGovern at 301–415–0681 or via email at Denise.McGovern@nrc.gov. * * * * * The NRC Commission Meeting Schedule can be found on the Internet at: https://www.nrc.gov/public-involve/ public-meetings/schedule.html. * * * * * The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If you need a reasonable accommodation to participate in these public meetings, or need this meeting notice or the transcript or other information from the public meetings in another format (e.g., braille, large print), please notify Kimberly Meyer, NRC Disability Program Manager, at 301–287–0739, by videophone at 240–428–3217, or by email at Kimberly.Meyer-Chambers@ nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. * * * * * Members of the public may request to receive this information electronically. If you would like to be added to the distribution, please contact the Nuclear Regulatory Commission, Office of the Secretary, Washington, DC 20555 (301– 415–1969), or email Brenda.Akstulewicz@nrc.gov or Patricia.Jimenez@nrc.gov. E:\FR\FM\14JYN1.SGM 14JYN1

Agencies

[Federal Register Volume 82, Number 134 (Friday, July 14, 2017)]
[Notices]
[Page 32587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14835]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Rescheduling Notification of the Public Teleconference of the 
President's Commission on Combating Drug Addiction and the Opioid 
Crisis (Commission)

AGENCY: Office of National Drug Control Policy (ONDCP).

ACTION: Notice of rescheduling of teleconference.

-----------------------------------------------------------------------

SUMMARY: ONDCP is issuing this notice to advise the public that the 
Commission is rescheduling the teleconference of the President's 
Commission on Combating Drug Addiction and the Opioid Crisis that was 
previously scheduled for Monday, July 17th at 4 p.m. EST. The purpose 
of the meeting is to review a draft interim report that will be posted 
on ONDCP's Commission Web site listed below before the teleconference.

DATES: The teleconference will be held on Monday, July 31st at 4 p.m. 
EST.

ADDRESSES: There will be no physical address. The public may call (800) 
260-0718 (Access Code 426289) to listen. Please call five minutes 
before the start time. If you are part of an organization, please try 
to consolidate use to as few lines as possible.

FOR FURTHER INFORMATION CONTACT: General information concerning the 
Commission and its meetings can be found on ONDCP's Web site at https://www.whitehouse.gov/ondcp/presidents-commission. Any member of the 
public who wants to obtain information about the Commission or its 
meetings that is not already on ONDCP's Web site or who wants to submit 
written comments for the Commission's consideration may contact Michael 
Passante, Designated Federal Officer (DFO) via email at 
commission@ondcp.eop.gov or telephone at (202) 395-6709. Please note 
that ONDCP may post such written comments publicly on our Web site, 
including names and contact information that are submitted.

SUPPLEMENTARY INFORMATION: The Commission was established in accordance 
with E.O. 13784 of March 29, 2017, the Commission's charter, and the 
provisions of the Federal Advisory Committee Act (FACA), as amended, 5 
U.S.C. App. 2, to obtain advice and recommendations for the President 
regarding drug issues. The Executive Order, charter, and information on 
the Members of the Commission are available on ONDCP's Web site. The 
Commission will function solely as an advisory body and will make 
recommendations regarding policies and practices for combating drug 
addiction with particular focus on the current opioid crisis in the 
United States. The Commission's final report is due October 1, 2017 
unless there is an extension. Per E.O. 13784, the Commission shall:
    a. Identify and describe the existing Federal funding used to 
combat drug addiction and the opioid crisis;
    b. Assess the availability and accessibility of drug addiction 
treatment services and overdose reversal throughout the country and 
identify areas that are underserved;
    c. Identify and report on best practices for addiction prevention, 
including healthcare provider education and evaluation of prescription 
practices, collaboration between State and Federal officials, and the 
use and effectiveness of State prescription drug monitoring programs;
    d. Review the literature evaluating the effectiveness of 
educational messages for youth and adults with respect to prescription 
and illicit opioids;
    e. Identify and evaluate existing Federal programs to prevent and 
treat drug addiction for their scope and effectiveness, and make 
recommendations for improving these programs; and;
    f. Make recommendations to the President for improving the Federal 
response to drug addiction and the opioid crisis.

    Dated: July 11, 2017.
Michael Passante,
Acting General Counsel, Designated Federal Officer.
[FR Doc. 2017-14835 Filed 7-13-17; 8:45 am]
BILLING CODE 3280-F5-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.